CLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk. Podcast Por  arte de portada

CLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk.

CLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk.

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

#DoctorPodcasts Episode 117:

Breast cancer kills 42,000+ women in the USA annually. Connie Lehman, MD, PhD & Jeff Luber, JD, MBA of CLAIRITY, Inc. have received FDA authorization for the first A.I.-powered mammography tool - CLAIRITY BREAST - that predicts 5-year cancer risk. It will save many lives. For details go to Clairity.com


Watch all 117 DoctorPodcasts || Cykiert Files video podcast interview episodes with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.


#BreastCancerPrediction

#FDAuthorizedAI

#ClairityBreast

#ArtificialIntelligence

#MammographyTool

#CancerRiskPrediction

#WomensHealth

#MedicalInnovation

#HealthcareTechnology

#DoctorPodcasts

#CykiertFiles

#Episode117

#ConnieLehman

#JeffLuber

#CLAIRITYInc

#FiveYearRisk

#EarlyDetection

#PersonalizedMedicine

#AIinHealthcare

#BreastCancerAwareness

#MedicalPodcasts

#HealthcareExperts

#InnovationInMedicine

#TechInHealthcare

#RiskAssessment

#PreventiveHealthcare

#DigitalHealth

#MedicalResearch

#ClinicalOncology

#ASCO2025

#FDAApproval

#HealthTech

#PrecisionMedicine

#CancerPrevention

#MammogramScreening

#AIHealthcareSolutions

#FutureOfMedicine

#HealthInnovation

#MedicalBreakthroughs

#PatientCare

#RobertCykiert

#RobertCykiertMD

Todavía no hay opiniones